ID   DRD1_RAT                Reviewed;         446 AA.
AC   P18901; P21669;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 2.
DT   02-OCT-2024, entry version 179.
DE   RecName: Full=D(1A) dopamine receptor;
DE   AltName: Full=Dopamine D1 receptor;
GN   Name=Drd1; Synonyms=Drd1a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=2168556; DOI=10.1073/pnas.87.17.6723;
RA   Monsma F.J. Jr., Mahan L.C., McVittie L.D., Gerfen C.R., Sibley D.R.;
RT   "Molecular cloning and expression of a D1 dopamine receptor linked to
RT   adenylyl cyclase activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:6723-6727(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2168520; DOI=10.1038/347076a0;
RA   Zhou Q.-Y., Grandy D.K., Thambi L., Kushner J.A., van Tol H.H.M., Cone R.,
RA   Pribnow D., Salon J., Bunzow J.R., Civelli O.;
RT   "Cloning and expression of human and rat D1 dopamine receptors.";
RL   Nature 347:76-80(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1402930; DOI=10.1111/j.1471-4159.1992.tb11023.x;
RA   Zhou Q.Y., Li C., Civelli O.;
RT   "Characterization of gene organization and promoter region of the rat
RT   dopamine D1 receptor gene.";
RL   J. Neurochem. 59:1875-1883(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 114-263.
RC   TISSUE=Corpus striatum;
RX   PubMed=2138567; DOI=10.1016/0014-5793(90)80140-e;
RA   O'Dowd B.F., Nguyen T., Tirpak A., Jarvie K.R., Israel Y., Seeman P.,
RA   Niznik H.B.;
RT   "Cloning of two additional catecholamine receptors from rat brain.";
RL   FEBS Lett. 262:8-12(1990).
RN   [5]
RP   INTERACTION WITH DNAJC14, GLYCOSYLATION, MUTAGENESIS OF PHE-333; PHE-337
RP   AND PHE-341, AND SUBCELLULAR LOCATION.
RX   PubMed=11331877; DOI=10.1038/35074561;
RA   Bermak J.C., Li M., Bullock C.M., Zhou Q.-Y.;
RT   "Regulation of transport of the dopamine D1 receptor by a new membrane-
RT   associated ER protein.";
RL   Nat. Cell Biol. 3:492-498(2001).
CC   -!- FUNCTION: Dopamine receptor whose activity is mediated by G proteins
CC       which activate adenylyl cyclase.
CC   -!- SUBUNIT: Interacts with DNAJC14 via its C-terminus (PubMed:11331877).
CC       Interacts with DRD2 (By similarity). {ECO:0000250|UniProtKB:Q61616,
CC       ECO:0000269|PubMed:11331877}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11331877};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11331877}. Endoplasmic
CC       reticulum membrane {ECO:0000269|PubMed:11331877}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:11331877}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q61616}. Cell projection, cilium membrane
CC       {ECO:0000250|UniProtKB:P21728}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell projection, dendritic spine
CC       {ECO:0000250|UniProtKB:Q61616}. Note=Transport from the endoplasmic
CC       reticulum to the cell surface is regulated by interaction with DNAJC14.
CC       {ECO:0000269|PubMed:11331877}.
CC   -!- TISSUE SPECIFICITY: Brain, in the striatum, the nucleus accumbens, and
CC       the olfactory tubercle.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11331877}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M35077; AAA70428.1; -; mRNA.
DR   EMBL; S46131; AAB23803.1; -; Genomic_DNA.
DR   PIR; A36049; DYRTD1.
DR   AlphaFoldDB; P18901; -.
DR   SMR; P18901; -.
DR   BioGRID; 246496; 5.
DR   CORUM; P18901; -.
DR   DIP; DIP-49024N; -.
DR   IntAct; P18901; 3.
DR   MINT; P18901; -.
DR   STRING; 10116.ENSRNOP00000034820; -.
DR   BindingDB; P18901; -.
DR   ChEMBL; CHEMBL265; -.
DR   DrugCentral; P18901; -.
DR   GuidetoPHARMACOLOGY; 214; -.
DR   GlyCosmos; P18901; 1 site, No reported glycans.
DR   GlyGen; P18901; 1 site.
DR   iPTMnet; P18901; -.
DR   PhosphoSitePlus; P18901; -.
DR   PaxDb; 10116-ENSRNOP00000034820; -.
DR   AGR; RGD:2518; -.
DR   RGD; 2518; Drd1.
DR   eggNOG; KOG3656; Eukaryota.
DR   InParanoid; P18901; -.
DR   PhylomeDB; P18901; -.
DR   PRO; PR:P18901; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0060170; C:ciliary membrane; ISO:RGD.
DR   GO; GO:0005929; C:cilium; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0044327; C:dendritic spine head; IDA:RGD.
DR   GO; GO:0044326; C:dendritic spine neck; IDA:RGD.
DR   GO; GO:0012505; C:endomembrane system; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097648; C:G protein-coupled receptor complex; ISO:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0097730; C:non-motile cilium; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0031701; F:angiotensin receptor binding; IPI:RGD.
DR   GO; GO:1990763; F:arrestin family protein binding; ISO:RGD.
DR   GO; GO:0051117; F:ATPase binding; IPI:RGD.
DR   GO; GO:0031750; F:D3 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0035240; F:dopamine binding; IMP:RGD.
DR   GO; GO:0004952; F:dopamine neurotransmitter receptor activity; ISO:RGD.
DR   GO; GO:0001588; F:dopamine neurotransmitter receptor activity, coupled via Gs; IDA:RGD.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IDA:RGD.
DR   GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IBA:GO_Central.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:RGD.
DR   GO; GO:1901363; F:heterocyclic compound binding; IPI:RGD.
DR   GO; GO:0032795; F:heterotrimeric G-protein binding; ISO:RGD.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007628; P:adult walking behavior; ISO:RGD.
DR   GO; GO:0008306; P:associative learning; IMP:RGD.
DR   GO; GO:0014002; P:astrocyte development; ISO:RGD.
DR   GO; GO:0001662; P:behavioral fear response; ISO:RGD.
DR   GO; GO:0048148; P:behavioral response to cocaine; IMP:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; IDA:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0071870; P:cellular response to catecholamine stimulus; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0021853; P:cerebral cortex GABAergic interneuron migration; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0001661; P:conditioned taste aversion; ISO:RGD.
DR   GO; GO:0021542; P:dentate gyrus development; ISO:RGD.
DR   GO; GO:0015872; P:dopamine transport; ISO:RGD.
DR   GO; GO:0042755; P:eating behavior; IDA:RGD.
DR   GO; GO:0007631; P:feeding behavior; ISO:RGD.
DR   GO; GO:0007212; P:G protein-coupled dopamine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; ISO:RGD.
DR   GO; GO:0046323; P:glucose import; ISO:RGD.
DR   GO; GO:0007625; P:grooming behavior; IDA:RGD.
DR   GO; GO:0046959; P:habituation; ISO:RGD.
DR   GO; GO:0021766; P:hippocampus development; ISO:RGD.
DR   GO; GO:0006886; P:intracellular protein transport; IMP:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; IMP:RGD.
DR   GO; GO:0060292; P:long-term synaptic depression; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0042711; P:maternal behavior; ISO:RGD.
DR   GO; GO:0007617; P:mating behavior; ISO:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:0099010; P:modification of postsynaptic structure; ISO:RGD.
DR   GO; GO:0006936; P:muscle contraction; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:RGD.
DR   GO; GO:1900038; P:negative regulation of cellular response to hypoxia; IMP:RGD.
DR   GO; GO:0042321; P:negative regulation of circadian sleep/wake cycle, sleep; IDA:RGD.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IDA:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; ISO:RGD.
DR   GO; GO:0035106; P:operant conditioning; IMP:RGD.
DR   GO; GO:0021769; P:orbitofrontal cortex development; IEP:RGD.
DR   GO; GO:0030432; P:peristalsis; ISO:RGD.
DR   GO; GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; ISO:RGD.
DR   GO; GO:2000253; P:positive regulation of feeding behavior; IMP:RGD.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0045838; P:positive regulation of membrane potential; IMP:RGD.
DR   GO; GO:2001224; P:positive regulation of neuron migration; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:RGD.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISO:RGD.
DR   GO; GO:0099170; P:postsynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:RGD.
DR   GO; GO:0042053; P:regulation of dopamine metabolic process; ISO:RGD.
DR   GO; GO:0043269; P:regulation of monoatomic ion transport; IDA:RGD.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0019229; P:regulation of vasoconstriction; IMP:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0032094; P:response to food; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0032526; P:response to retinoic acid; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0046960; P:sensitization; ISO:RGD.
DR   GO; GO:0035176; P:social behavior; IMP:RGD.
DR   GO; GO:0021756; P:striatum development; IEP:RGD.
DR   GO; GO:0007416; P:synapse assembly; IEP:BHF-UCL.
DR   GO; GO:0001963; P:synaptic transmission, dopaminergic; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; ISO:RGD.
DR   GO; GO:0001659; P:temperature homeostasis; ISO:RGD.
DR   GO; GO:0019226; P:transmission of nerve impulse; ISO:RGD.
DR   GO; GO:0042311; P:vasodilation; IEA:InterPro.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR001413; Dopamine_D1_rcpt.
DR   InterPro; IPR000929; Dopamine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24248; ADRENERGIC RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24248:SF139; D(1A) DOPAMINE RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00565; DOPAMINED1AR.
DR   PRINTS; PR00242; DOPAMINER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Disulfide bond; Endoplasmic reticulum;
KW   G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane; Palmitate;
KW   Receptor; Reference proteome; Synapse; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..446
FT                   /note="D(1A) dopamine receptor"
FT                   /id="PRO_0000069378"
FT   TOPO_DOM        1..22
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        23..48
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        49..59
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        60..86
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        87..95
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        96..118
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        119..137
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        138..162
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        163..192
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        193..218
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        219..272
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        273..299
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        300..312
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        313..337
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        338..446
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   LIPID           347
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           351
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        4
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        95..186
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   MUTAGEN         333
FT                   /note="F->A: Loss of interaction with DNAJC14. Abolishes
FT                   transport to the cell surface."
FT                   /evidence="ECO:0000269|PubMed:11331877"
FT   MUTAGEN         337
FT                   /note="F->A: Loss of interaction with DNAJC14. Abolishes
FT                   transport to the cell surface."
FT                   /evidence="ECO:0000269|PubMed:11331877"
FT   MUTAGEN         341
FT                   /note="F->A: Loss of interaction with DNAJC14. Abolishes
FT                   transport to the cell surface."
FT                   /evidence="ECO:0000269|PubMed:11331877"
FT   CONFLICT        91
FT                   /note="L -> F (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        93
FT                   /note="P -> S (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        165
FT                   /note="A -> T (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        190
FT                   /note="L -> F (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="R -> G (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        253
FT                   /note="C -> W (in Ref. 2)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   446 AA;  49428 MW;  0380042E8590F470 CRC64;
     MAPNTSTMDE AGLPAERDFS FRILTACFLS LLILSTLLGN TLVCAAVIRF RHLRSKVTNF
     FVISLAVSDL LVAVLVMPWK AVAEIAGFWP LGPFCNIWVA FDIMCSTASI LNLCVISVDR
     YWAISSPFQY ERKMTPKAAF ILISVAWTLS VLISFIPVQL SWHKAKPTWP LDGNFTSLED
     TEDDNCDTRL SRTYAISSSL ISFYIPVAIM IVTYTSIYRI AQKQIRRISA LERAAVHAKN
     CQTTAGNGNP VECAQSESSF KMSFKRETKV LKTLSVIMGV FVCCWLPFFI SNCMVPFCGS
     EETQPFCIDS ITFDVFVWFG WANSSLNPII YAFNADFQKA FSTLLGCYRL CPTTNNAIET
     VSINNNGAVV FSSHHEPRGS ISKDCNLVYL IPHAVGSSED LKKEEAGGIA KPLEKLSPAL
     SVILDYDTDV SLEKIQPVTH SGQHST
//
